290
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Acute cannabis consumption and motor vehicle collision risk: systematic review of observational studies and meta-analysis

      research-article
      , ,
      BMJ : British Medical Journal
      BMJ Publishing Group Ltd.

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objective To determine whether the acute consumption of cannabis (cannabinoids) by drivers increases the risk of a motor vehicle collision.

          Design Systematic review of observational studies, with meta-analysis.

          Data sources We did electronic searches in 19 databases, unrestricted by year or language of publication. We also did manual searches of reference lists, conducted a search for unpublished studies, and reviewed the personal libraries of the research team.

          Review methods We included observational epidemiology studies of motor vehicle collisions with an appropriate control group, and selected studies that measured recent cannabis use in drivers by toxicological analysis of whole blood or self report. We excluded experimental or simulator studies. Two independent reviewers assessed risk of bias in each selected study, with consensus, using the Newcastle-Ottawa scale. Risk estimates were combined using random effects models.

          Results We selected nine studies in the review and meta-analysis. Driving under the influence of cannabis was associated with a significantly increased risk of motor vehicle collisions compared with unimpaired driving (odds ratio 1.92 (95% confidence interval 1.35 to 2.73); P=0.0003); we noted heterogeneity among the individual study effects (I 2=81). Collision risk estimates were higher in case-control studies (2.79 (1.23 to 6.33); P=0.01) and studies of fatal collisions (2.10 (1.31 to 3.36); P=0.002) than in culpability studies (1.65 (1.11 to 2.46); P=0.07) and studies of non-fatal collisions (1.74 (0.88 to 3.46); P=0.11).

          Conclusions Acute cannabis consumption is associated with an increased risk of a motor vehicle crash, especially for fatal collisions. This information could be used as the basis for campaigns against drug impaired driving, developing regional or national policies to control acute drug use while driving, and raising public awareness.

          Related collections

          Most cited references25

          • Record: found
          • Abstract: found
          • Article: not found

          Cannabis and the brain.

          The active compound in herbal cannabis, Delta(9)-tetrahydrocannabinol, exerts all of its known central effects through the CB(1) cannabinoid receptor. Research on cannabinoid mechanisms has been facilitated by the availability of selective antagonists acting at CB(1) receptors and the generation of CB(1) receptor knockout mice. Particularly important classes of neurons that express high levels of CB(1) receptors are GABAergic interneurons in hippocampus, amygdala and cerebral cortex, which also contain the neuropeptides cholecystokinin. Activation of CB(1) receptors leads to inhibition of the release of amino acid and monoamine neurotransmitters. The lipid derivatives anandamide and 2-arachidonylglycerol act as endogenous ligands for CB(1) receptors (endocannabinoids). They may act as retrograde synaptic mediators of the phenomena of depolarization-induced suppression of inhibition or excitation in hippocampus and cerebellum. Central effects of cannabinoids include disruption of psychomotor behaviour, short-term memory impairment, intoxication, stimulation of appetite, antinociceptive actions (particularly against pain of neuropathic origin) and anti-emetic effects. Although there are signs of mild cognitive impairment in chronic cannabis users there is little evidence that such impairments are irreversible, or that they are accompanied by drug-induced neuropathology. A proportion of regular users of cannabis develop tolerance and dependence on the drug. Some studies have linked chronic use of cannabis with an increased risk of psychiatric illness, but there is little evidence for any causal link. The potential medical applications of cannabis in the treatment of painful muscle spasms and other symptoms of multiple sclerosis are currently being tested in clinical trials. Medicines based on drugs that enhance the function of endocannabinoids may offer novel therapeutic approaches in the future.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Pharmacology and effects of cannabis: a brief review.

            Increasing prevalence of recreational cannabis use among the young population has stimulated debate on the possible effects of acute and longterm use. To highlight recent knowledge of mechanisms of action, effects on psychomotor and cognitive performance, and health risks associated with cannabis consumption. A brief review of recent literature on the prevalence of recreational cannabis use, the potency of modern cannabis preparations and the pharmacological actions of cannabis. Cannabinoids derived from herbal cannabis interact with endogenous cannabinoid systems in the body. Actions on specific brain receptors cause dose-related impairments of psychomotor performance with implications for car and train driving, aeroplane piloting and academic performance. Other constituents of cannabis smoke carry respiratory and cardiovascular health risks similar to those of tobacco smoke. Cannabis is not, as widely perceived, a harmless drug but poses risks to the individual and to society.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Addiction

              In the United States, 21.6 million individuals older than 12 are diagnosed with abuse or dependence to drugs and/or alcohol each year [1]. Consequently, direct and indirect costs to society stemming from addiction total more than $700 billion annually in the United States alone [1]. Addiction to drugs and alcohol has long been recognized as a mental health disorder, appearing in some form in the Diagnostic and Statistical Manual of Mental Disorders (DSM) since its inception in 1952 [2]. However, only recently have non-drug addictions (e.g., food and behavioral addictions) begun to gain increased acceptance as potentially classifiable addictions, as emphasized by the American Psychiatric Association’s (APA) reclassification of pathological gambling into the Substance-Related and Addictive Disorders category in the recent DSM-5 [3]. Only a minority of individuals who drink alcohol, smoke, or use drugs develop pathological use. The same can be said of individuals who eat, gamble, play online video games, or engage in other behaviors that might become addictive. Even individuals who engage in heavy drinking or who are obese may not meet suggested criteria for pathological alcohol use or eating behavior. Furthermore, in lesser amounts, using alcohol, using drugs, or engaging in behaviors with addiction-like potential may provide benefits. Thus, a spectrum of use exists, begging the question of where to draw the line between heavy use and addictive use. Clinical definitions distinguish heavy from pathological use by a continuation of use despite adverse consequences and a presence of distress, but in practice, this distinction is often difficult to make. In exploring substances and behaviors with addictive potential, it is critical to obtain a multifaceted, unbiased understanding of how the substances and behaviors both benefit and harm individuals and society in order to best discover policies and treatments to address addiction. In this issue of the Yale Journal of Biology and Medicine, the editors present articles on a variety of topics related to addiction in order to provide an informative, well-rounded depiction of drug and alcohol use, maladaptive behaviors, and potential policies and treatments related to addiction. The editors have selected articles that highlight areas within addiction that are emerging in importance. Original research presented by Serafini and Stewart demonstrates the importance of perceptions of sibling’s alcohol use on the likelihood of drinking alcohol in young adults. Rutherford and colleagues also present original research, investigating the differences in brain structure between substance-using and non-substance-using mothers and how maternal substance use relates to general motivation. Often people have the mindset that any drug prescribed by a doctor in a medical setting is safe from addiction and abuse, but clinicians know otherwise. In this issue, Tetrault and Butner provide an overview of the increasing rates of non-medical prescription opioid use and the accompanying growing dangers of addiction and overdose. Hawk and colleagues review strategies aimed at reducing fatalities from opioid overdose, which are becoming more common in the United States from increased prescription opioid use. Weaver also describes misuse and abuse of prescription sedatives such as benzodiazepines. Additionally, drugs such as marijuana have been demonstrated to have potential medical uses despite being illegal to prescribe by physicians in most U.S. states. Hall reviews the policy changes that have been made with the increased adoption of medical marijuana in the United States. Sun and colleagues review the effectiveness and safety of the use of marijuana for treatment of glaucoma. Understanding the benefits of drugs of abuse is important for policy and prevention targeted toward reducing addiction. Smoking tobacco and obesity are the two leading causes of preventable death in the United States [4]. Annamalai reviews the importance of encouraging patients with serious mental illness to attempt smoking cessation, an important topic since the rates of smoking among people with serious mental illness remain much higher than the general population. Wickham reviews the biology of how menthol interacts with nicotine, which is an imperative line of research to study given the growing market for flavored electronic cigarettes. Rupprecht reviews the intersection and interrelation of the two health hazards of obesity and smoking. Additionally, Meule chronicles the history of food addiction research. An enhanced understanding of non-drug addictions is emerging in importance as the APA promotes researching more behavioral addictions for inclusion in the next edition of the DSM. In this vein, Szabo details the importance of coming to a common consensus about what constitutes a behavioral addiction as he discusses the particular case of exercise addiction. Xu and colleagues review the research on video game addiction and detail the associated risk of addiction when developing video games to treat amblyopia. Voss and colleagues describe a case report of pornography use-associated Internet Gaming Disorder, a behavioral addiction garnering increasing attention. Treatment development is another area of active investigation in the field of addiction, and several relevant articles are contained in this issue. Xu and colleagues describe a novel technique using transcranial direct current stimulation (tDCS) to increase activity in both sides of the prefrontal cortex, and the authors discuss the potential for treating addiction using tDCS intervention. Melemis offers his perspective on maintaining recovery from addiction using five rules to avoid relapse. Heshmat describes recovery from addiction from a behavioral economics perspective, offering his insight into how best to achieve abstinence. Additionally, Robertson-Boersma and colleagues discuss the potential for peer intervention to reduce binge alcohol drinking in college students. It is crucial for society to continue to increase its understanding of addiction to drugs, alcohol, and behaviors in order to establish improved behavioral and pharmacological treatments for addiction. Additionally, continued unbiased discussion about addiction will allow society to develop and implement effective public policy that balances both the detrimental and beneficial effects of drugs, alcohol, and addictive behaviors. Lastly, additional research into non-drug addictions is essential in order that a valid and reliable diagnostic system can be created to better identify and treat addictions to food, exercise, video games, etc. in a clinical setting. The articles presented in this issue aim to advance society one step further in its knowledge and understanding of addiction.
                Bookmark

                Author and article information

                Contributors
                Role: associate professor
                Role: assistant professor
                Role: research coordinator
                Journal
                BMJ
                bmj
                BMJ : British Medical Journal
                BMJ Publishing Group Ltd.
                0959-8138
                1468-5833
                2012
                2012
                09 February 2012
                : 344
                : e536
                Affiliations
                [1 ]Department of Community Health and Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada B3H 1V7
                Author notes
                Correspondence to: M Asbridge mark.asbridge@ 123456dal.ca
                Article
                asbm000872
                10.1136/bmj.e536
                3277079
                22323502
                c6aca628-3cae-479a-a7ae-94d197ef3dd4
                © Asbridge et al 2012

                This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode.

                History
                : 12 December 2011
                Categories
                Research
                1600
                Epidemiologic Studies
                CME

                Medicine
                Medicine

                Comments

                Comment on this article